-
Je něco špatně v tomto záznamu ?
Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability
Z. Knejzlík, K. Herkommerová, D. Hocková, I. Pichová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1916 do Před 6 měsíci
Freely Accessible Science Journals
od 1916 do Před 6 měsíci
PubMed Central
od 1916 do Před 1 rokem
Europe PubMed Central
od 1916 do Před 6 měsíci
Open Access Digital Library
od 1916-01-01
Open Access Digital Library
od 1916-01-01
PubMed
31818925
DOI
10.1128/jb.00710-19
Knihovny.cz E-zdroje
- MeSH
- antituberkulotika chemie farmakologie MeSH
- hypoxanthinfosforibosyltransferasa antagonisté a inhibitory chemie genetika metabolismus MeSH
- inhibitory enzymů chemie farmakologie MeSH
- katalýza MeSH
- metabolické sítě a dráhy MeSH
- mikrobiální viabilita MeSH
- Mycobacterium smegmatis genetika růst a vývoj metabolismus MeSH
- plazmidy genetika MeSH
- puriny metabolismus MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Purine metabolism plays a ubiquitous role in the physiology of Mycobacterium tuberculosis and other mycobacteria. The purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is essential for M. tuberculosis growth in vitro; however, its precise role in M. tuberculosis physiology is unclear. Membrane-permeable prodrugs of specifically designed HGPRT inhibitors arrest the growth of M. tuberculosis and represent potential new antituberculosis compounds. Here, we investigated the purine salvage pathway in the model organism Mycobacterium smegmatis Using genomic deletion analysis, we confirmed that HGPRT is the only guanine and hypoxanthine salvage enzyme in M. smegmatis but is not required for in vitro growth of this mycobacterium or survival under long-term stationary-phase conditions. We also found that prodrugs of M. tuberculosis HGPRT inhibitors displayed an unexpected antimicrobial activity against M. smegmatis that is independent of HGPRT. Our data point to a different mode of mechanism of action for these inhibitors than was originally proposed.IMPORTANCE Purine bases, released by the hydrolytic and phosphorolytic degradation of nucleic acids and nucleotides, can be salvaged and recycled. The hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which catalyzes the formation of guanosine-5'-monophosphate from guanine and inosine-5'-monophosphate from hypoxanthine, represents a potential target for specific inhibitor development. Deletion of the HGPRT gene (Δhgprt) in the model organism Mycobacterium smegmatis confirmed that this enzyme is not essential for M. smegmatis growth. Prodrugs of acyclic nucleoside phosphonates (ANPs), originally designed against HGPRT from Mycobacterium tuberculosis, displayed anti-M. smegmatis activities comparable to those obtained for M. tuberculosis but also inhibited the ΔhgprtM. smegmatis strain. These results confirmed that ANPs act in M. smegmatis by a mechanism independent of HGPRT.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028508
- 003
- CZ-PrNML
- 005
- 20210114154103.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/JB.00710-19 $2 doi
- 035 __
- $a (PubMed)31818925
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Knejzlík, Zdeněk $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
- 245 10
- $a Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability / $c Z. Knejzlík, K. Herkommerová, D. Hocková, I. Pichová,
- 520 9_
- $a Purine metabolism plays a ubiquitous role in the physiology of Mycobacterium tuberculosis and other mycobacteria. The purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is essential for M. tuberculosis growth in vitro; however, its precise role in M. tuberculosis physiology is unclear. Membrane-permeable prodrugs of specifically designed HGPRT inhibitors arrest the growth of M. tuberculosis and represent potential new antituberculosis compounds. Here, we investigated the purine salvage pathway in the model organism Mycobacterium smegmatis Using genomic deletion analysis, we confirmed that HGPRT is the only guanine and hypoxanthine salvage enzyme in M. smegmatis but is not required for in vitro growth of this mycobacterium or survival under long-term stationary-phase conditions. We also found that prodrugs of M. tuberculosis HGPRT inhibitors displayed an unexpected antimicrobial activity against M. smegmatis that is independent of HGPRT. Our data point to a different mode of mechanism of action for these inhibitors than was originally proposed.IMPORTANCE Purine bases, released by the hydrolytic and phosphorolytic degradation of nucleic acids and nucleotides, can be salvaged and recycled. The hypoxanthine-guanine phosphoribosyltransferase (HGPRT), which catalyzes the formation of guanosine-5'-monophosphate from guanine and inosine-5'-monophosphate from hypoxanthine, represents a potential target for specific inhibitor development. Deletion of the HGPRT gene (Δhgprt) in the model organism Mycobacterium smegmatis confirmed that this enzyme is not essential for M. smegmatis growth. Prodrugs of acyclic nucleoside phosphonates (ANPs), originally designed against HGPRT from Mycobacterium tuberculosis, displayed anti-M. smegmatis activities comparable to those obtained for M. tuberculosis but also inhibited the ΔhgprtM. smegmatis strain. These results confirmed that ANPs act in M. smegmatis by a mechanism independent of HGPRT.
- 650 _2
- $a antituberkulotika $x chemie $x farmakologie $7 D000995
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a inhibitory enzymů $x chemie $x farmakologie $7 D004791
- 650 _2
- $a hypoxanthinfosforibosyltransferasa $x antagonisté a inhibitory $x chemie $x genetika $x metabolismus $7 D007041
- 650 _2
- $a metabolické sítě a dráhy $7 D053858
- 650 _2
- $a mikrobiální viabilita $7 D050296
- 650 _2
- $a Mycobacterium smegmatis $x genetika $x růst a vývoj $x metabolismus $7 D020102
- 650 _2
- $a plazmidy $x genetika $7 D010957
- 650 _2
- $a puriny $x metabolismus $7 D011687
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Herkommerová, Klára $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Hocková, Dana $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic.
- 700 1_
- $a Pichová, Iva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic iva.pichova@uochb.cas.cz.
- 773 0_
- $w MED00002537 $t Journal of bacteriology $x 1098-5530 $g Roč. 202, č. 5 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31818925 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154100 $b ABA008
- 999 __
- $a ok $b bmc $g 1608843 $s 1119688
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 202 $c 5 $e 20200211 $i 1098-5530 $m Journal of bacteriology $n J Bacteriol $x MED00002537
- LZP __
- $a Pubmed-20210105